Cholestasis induces apoptosis in mice cardiac cells: The possible role of nitric oxide and oxidative stress

Liver International

Volumn 30, Issue 6, 2010, Pages 898-905

  Shafaroodi, Hamed ^a   Ebrahimi, Farzad ^b   Moezi, Leila ^c   Hashemi, Mehrdad ^d   Doostar, Yousef ^e   Ghasemi, Mehdi ^f,g   Dehpour, Ahmad Reza ^f  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e ISLAMIC AZAD UNIVERSITY   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cholestasis; Heart; Mice; Nitric oxide; Reactive oxygen species

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; ENZYME INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; HEART MUSCLE CELL; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; ANIMAL; ANTAGONISTS AND INHIBITORS; BILE DUCT; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; HEART DISEASES; HEART MUSCLE; LIGATION; METABOLISM; PATHOLOGY; SURGERY;

ANIMALS; APOPTOSIS; BILE DUCTS; CATALASE; CHOLESTASIS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GLUTATHIONE PEROXIDASE; HEART DISEASES; LIGATION; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MICE; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 77954381149     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02249.x     Document Type: Article

References (49)

1. Bomzon A, Rosenberg M, Gali D. Systemic hypotension and decreased pressor response in dogs with chronic bile duct ligation. Hepatology 1986, 6:595-600.
2. Mani AR, Nahavandi A, Moosavi M, Safarinejad R, Dehpour AR. Dual nitric oxide mechanisms of cholestasis-induced bradycardia in the rat. Clin Exp Pharmacol Physiol 2002, 29:905-8.
3. Tajuddin M, Tariq M, Bilgrami NL, Kumar S. Biochemical and pathological changes in the heart following bile duct ligation. Adv Myocardiol 1980, 2:209-12.
4. Namiranian K, Samini M, Mehr SE. Mesenteric vascular bed responsiveness in bile duct-ligated rats: roles of opioid and nitric oxide systems. Eur J Pharmacol 2001, 423:185-93.
5. Ebrahimi F, Tavakoli S, Hajrasouliha AR. Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats. Eur J Pharmacol 2005, 523:93-100.
6. Zollinger RM, Williams RD. Surgical aspects of jaundice. Surgery 1956, 39:1016-30.
7. Baron V, Muriel P. Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat. Biochim Biophys Acta 1999, 1472:173-80.
8. Holt S, Marley R, Fernando B. Acute cholestasis-induced renal failure: effects of antioxidants and ligands for the thromboxane a2 receptor. Kidney Int 1999, 55:271-7.
9. Ljubuncic P, Tanne Z, Bomzon A. Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut 2000, 47:710-6.
10. Haddad JJ. Redox and oxidant-mediated regulation of apoptosis signaling pathways: immuno-pharmaco-redox conception of oxidative siege versus cell death commitment. Int Immunopharmacol 2004, 4:475-93.
11. Rust C, Gores GJ. Apoptosis and liver disease. Am J Med 2000, 108:567-74.
12. Guicciardi ME, Gores GJ. Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease. Dig Liver Dis 2002, 34:387-92.
13. Dimmeler S, Zeiher AM. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1997, 1:275-81.
14. Homayoun H, Sayyah M, Dehpour AR. The additive effect of opioids and nitric oxide in increasing pentylenetetrazole-induced seizure threshold in cholestatic mice. J Gastroenterol Hepatol 2002, 17:96-101.
15. Cai L, Chen S, Evans T. Apoptotic germ-cell death and testicular damage in experimental diabetes: prevention by endothelin antagonism. Urol Res 2000, 28:342-7.
16. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-8.
17. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-6.
18. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-69.
19. Paoletti F, Mocali A. Determination of superoxide dismutase activity by purely chemical system based on nad(p)h oxidation. Methods Enzymol 1990, 186:209-20.
20. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990, 36((Part 1)):1440-3.
21. Liu H, Lee SS. Cardiopulmonary dysfunction in cirrhosis. J Gastroenterol Hepatol 1999, 14:600-8.
22. Ebrahimi F, Tavakoli S, Hajrasouliha AR. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats. Fundam Clin Pharmacol 2006, 20:461-71.
23. Trevisani F, Merli M, Savelli F. Qt interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. J Hepatol 2003, 38:461-7.
24. Bernardi M, Calandra S, Colantoni A. Q-t interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 1998, 27:28-34.
25. Ma Z, Zhang Y, Huet PM, Lee SS. Differential effects of jaundice and cirrhosis on beta-adrenoceptor signaling in three rat models of cirrhotic cardiomyopathy. J Hepatol 1999, 30:485-91.
26. Rayes N, Bechstein WO, Keck H. Cause of death after liver transplantation: An analysis of 41 cases in 382 patients. Zentralbl Chir 1995, 120:435-8.
27. Franco D, Vons C, Traynor O, De Smadja C. Should portosystemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis? Arch Surg 1988, 123:987-91.
28. Chowdhary S, Ng GA, Nuttall SL. Nitric oxide and cardiac parasympathetic control in human heart failure. Clin Sci (Lond) 2002, 102:397-402.
29. Massion PB, Feron O, Dessy C, Balligand JL. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 2003, 93:388-98.
30. Paton JF, Kasparov S, Paterson DJ. Nitric oxide and autonomic control of heart rate: a question of specificity. Trends Neurosci 2002, 25:626-31.
31. Hajrasouliha AR, Tavakoli S, Jabehdar-Maralani P. Resistance of cholestatic rats against epinephrine-induced arrhythmia: the role of nitric oxide and endogenous opioids. Eur J Pharmacol 2004, 499:307-13.
32. Tsai LY, Lee KT, Tsai SM, Lee SC, Yu HS. Changes of lipid peroxide levels in blood and liver tissue of patients with obstructive jaundice. Clin Chim Acta 1993, 215:41-50.
33. Ono M, Sekiya C, Ohhira M. Elevated level of serum mn-superoxide dismutase in patients with primary biliary cirrhosis: possible involvement of free radicals in the pathogenesis in primary biliary cirrhosis. J Lab Clin Med 1991, 118:476-83.
34. Assimakopoulos SF, Vagianos CE, Zervoudakis G. Gut regulatory peptides bombesin and neurotensin reduce hepatic oxidative stress and histological alterations in bile duct ligated rats. Regul Pept 2004, 120:185-93.
35. Assimakopoulos SF, Vagianos CE, Patsoukis N. Evidence for intestinal oxidative stress in obstructive jaundice-induced gut barrier dysfunction in rats. Acta Physiol Scand 2004, 180:177-85.
36. Ara C, Karabulut AB, Kirimlioglu H. Protective effect of resveratrol against renal oxidative stress in cholestasis. Ren Fail 2005, 27:435-40.
37. Chroni E, Patsoukis N, Karageorgos N, Konstantinou D, Georgiou C. Brain oxidative stress induced by obstructive jaundice in rats. J Neuropathol Exp Neurol 2006, 65:193-8.
38. Tieppo J, Vercelino R, Dias AS. Evaluation of the protective effects of quercetin in the hepatopulmonary syndrome. Food Chem Toxicol 2007, 45:1140-6.
39. Tsai LY, Lee KT, Liu TZ. Evidence for accelerated generation of hydroxyl radicals in experimental obstructive jaundice of rats. Free Radic Biol Med 1998, 24:732-7.
40. Assimakopoulos SF, Mavrakis AG, Grintzalis K. Superoxide radical formation in diverse organs of rats with experimentally induced obstructive jaundice. Redox Rep 2008, 13:179-84.
41. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, 271((5 Pt 1)):C1424-37.
42. Schimke I, Schikora M, Meyer R. Oxidative stress in the human heart is associated with changes in the antioxidative defense as shown after heart transplantation. Mol Cell Biochem 2000, 204:89-96.
43. Mailer K, Macleod I, Morris W. Age related changes in anti-oxidative enzymes in cardiomyopathic hamster hearts. Mech Ageing Dev 1991, 59:37-45.
44. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 2000, 29:323-33.
45. Czaja MJ. Induction and regulation of hepatocyte apoptosis by oxidative stress. Antioxid Redox Signal 2002, 4:759-67.
46. Ferreira M, Coxito PM, Sardão VA, Palmeira CM, Oliveira PJ. Bile acids are toxic for isolated cardiac mitochondria: a possible cause for hepatic-derived cardiomyopathies? Cardiovasc Toxicol 2005, 5:63-73.
47. Gorelik J, Shevchuk A, de Swiet M. Comparison of the arrhythmogenic effects of tauro- and glycoconjugates of cholic acid in an in vitro study of rat cardiomyocytes. BJOG 2004, 111:867-70.
48. Rivard AL, Steer CJ, Kren BT. Administration of tauroursodeoxycholic acid (TUDCA) reduces apoptosis following myocardial infarction in rat. Am J Chin Med 2007, 35:279-95.
49. Razavi HM, Hamilton JA, Feng Q. Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther 2005, 106:147-62.